Home
Board Review Course
All Courses
Publication Updates
Resident
Videos
Study Summaries
Calculators
Chemotherapy Cards
Mentorship
Support and Policies

Subscribe

NRG-GY012: Olaparib, Cediranib, and Olaparib+Cediranib vs. Cediranib in Recurrent Endometrial Cancer

Last updated on Jun 8, 2026

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Previous Feedback

Next Nasogastric Tubes

GYOEDU Plus © 2026

Sign up

Powered by Ghost